314
Participants
Start Date
September 30, 2002
Primary Completion Date
March 31, 2006
Study Completion Date
October 31, 2009
comparative genomic hybridization
cytogenetic analysis
fluorescence in situ hybridization
immunohistochemistry staining method
Memorial Sloan-Kettering Cancer Center, New York
Charles R. Wood Cancer Center at Glens Falls Hospital, Glens Falls
CCOP - Hematology-Oncology Associates of Central New York, Syracuse
Community General Hospital of Greater Syracuse, Syracuse
Danville Regional Medical Center, Danville
Wayne Memorial Hospital, Incorporated, Goldsboro
Wayne Radiation Oncology, Goldsboro
Roper St. Francis Cancer Center at Roper Hospital, Charleston
Iowa Blood and Cancer Care, Cedar Rapids
St. Luke's Hospital, Cedar Rapids
Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids
Fairview University Medical Center - University Campus, Minneapolis
Capital Region Cancer Center, Jefferson City
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia
University of Chicago Cancer Research Center, Chicago
Massachusetts General Hospital Cancer Center, Boston
Brigham and Women's Hospital, Boston
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
Commonwealth Hematology-Oncology P.C. - Worcester, Worcester
Kingsbury Center for Cancer Care at Cheshire Medical Center, Keene
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon
Wilson Medical Center, Wilson
Wake Forest University Comprehensive Cancer Center, Winston-Salem
Rhode Island Hospital, Providence
Miriam Hospital at Lifespan, Providence
Mountainview Medical, Berlin Corners
Fletcher Allen Health Care - University Health Center Campus, Burlington
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER